The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSareum Share News (SAR)

Share Price Information for Sareum (SAR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 41.75
Bid: 41.00
Ask: 42.50
Change: 5.25 (14.38%)
Spread: 1.50 (3.659%)
Open: 37.00
High: 42.50
Low: 36.00
Prev. Close: 36.50
SAR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EARNINGS AND TRADING: MetalNRG hails Gold Ridge findings

Thu, 09th Nov 2023 13:47

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

----------

MetalNRG PLC - London-based natural resources and energy-focused investor - Says results from geologic soil sampling programme at Gold Ridge property in Arizona, US "support its previous belief that there is a real possibility of a larger undiscovered gold/base metal system". Programme finds "strong gold, copper, lead and zinc mineralisation related to the Mascot Stock". There is also "Strong gold, silver, arsenic, lead and zinc mineralisation related to the Apache Pass Shear zone". Tests also show a new gold, copper, lead and zinc trend in the Precambrian block. Executive Director Rolf Gerritsen says: "We are delighted with these results which confirm that whilst there is follow up work to be carried out, there is a real gold and indeed wider opportunity at Gold Ridge."

----------

Panthera Resources PLC - gold explorer and developer with assets in India and West Africa - Australian unit Indo Gold Pty Ltd preparing to deliver notice of dispute to India's government. Delivery is expected in the fourth-quarter of the year. The dispute concerns an alleged breach by India of a treaty with Australia on the Promotion & Protection of Investments. Panthera adds: "Following the delivery of the notice of dispute and in the absence of any meaningful correspondence in relation to this matter from the government of India or if no amicable settlement is reached, IGPL will subsequently deliver a notice of arbitration to the government of India. Any such notice of arbitration is anticipated to be delivered to the government of India in the first quarter of 2024. Under the Treaty, an arbitral tribunal is to be constituted within two months of delivery of the notice of arbitration." Panthera also notes a Times of India report that the gold deposit at the Bhukia asset "could be worth over USD1 billion", based on information from the Geological Survey of India. Panthera adds: "This valuation has not been independently verified by the company. Accordingly, while at this stage the company is not able to make any comments in relation to the potential quantum of damages that IGPL will claim from India, the company will in due course, announce the actual quantum of damages that IGPL will claim from India when available."

Panthera first invested in Bhukia, via its Australian unit, back in January 2005. A prospecting licence at the asset was rejected by the government of Rajasthan in August 2018 on "various spurious and legally untenable grounds", according to Panthera. Under the terms of an act passed in India in 2021, Panthera believes it has the rights to "fair and equitable compensation, not merely reimbursement of expenditures".

----------

United Oil & Gas PLC - oil and gas company focused on Egypt and Jamaica - In Jamaica, it notes it is currently engaged in discussions with a preferred potential partner to work alongside United Oil in the Walton Morant licence. United Oil adds: "Furthermore, the company is engaging with the Jamaican authorities to secure an extension to the current licence period which expires at the end of January 2024, so as to provide sufficient time to progress additional technical work on the block to support the drilling of an exploration well." In Egypt, working interest production averages 1,024 barrels of oil equivalent per day for the year to November 5, in line with 2023 outlook between 930 to 1,030 boepd. United Oil adds: "The full-year guidance includes production from the current wells and contributions from workover activity currently being undertaken on the fields." It cautions that the macroeconomic environment in Egypt, characterised by reduced US dollar liquidity as deteriorated. Less US dollar liquidity has impacted its ability to repatriate funds from Egypt. "Whilst Egyptian General Petroleum Corp has continued to make regular payments to the company against the receivable balance, including Egyptian pound payments equivalent to USD1.8 million since the 31 October, no USD payments have been received since August 2023," United Oil says.

----------

PCI-PAL PLC - Suffolk, England-based global cloud provider of secure payment solutions for business communications - Revenue in financial year ended June 30 increases 25% to GBP14.9 million from GBP11.9 million. Pretax loss widens to GBP4.9 million from GBP3.1 million, however. Administrative expenses climb 37% to GBP17.9 million. Non-Executive Chair Simon Wilson says: "I continue to be both excited and encouraged by the progress that has been made by the group in FY23, and the board is confident in the outlook and prospects in FY24 and beyond. Given the momentum in the business I look forward to sharing further progress reports and news during the coming year, as we continue our strategic growth journey towards profitability and further scale."

----------

Concurrent Technologies PLC - Essex, England-based designer and manufacturer of computer boards - Launches its "highest performance plug in card" yet. The new offering has "enhanced operational performance unlocked using an emerging cooling technology". It adds: "Previously, the PIC was cooled via conduction, while the new variant uses air flowing through a heat exchanger built into the product. This heat exchanger has been optimised using thermal simulations and verified through extensive testing to ensure it operates at peak performance under harsh environmental conditions. The benefit for customers is that they can extract more performance from the same physical card."

----------

Sareum Holdings PLC - Cambridge, England-based biotechnology firm - Announces first dosing of patients in food effect part of phase 1a probe of autoimmune therapy SDC-1801. This portion of the study probes how food consumption changes, if at all, the efficacy of the product. It will help determine whether the product must be taken on an empty stomach, for example. SDC-1801 will have an initial focus on psoriasis, an autoimmune condition affecting the skin.

----------

Amala Foods PLC - cash shell - Shares in the company are temporarily suspended as it enters into a binding agreement that could lead to reverse takeover of healthcare firm Dialysis Care Plus Inc. DCP is "building dialysis centres in the Philippines where the market for dialysis services is growing substantially every year". Amala adds: "The team has an excellent track record with internationally known healthcare groups in the USA as well as locally in the Philippines. The valuation approach that is being considered is one whereby upon a successful transaction the valuation paid would be based upon a share consideration and a deferred share consideration determined by financial performance. The company expects to conclude matters shortly and will provide further updates to the market this month." For the half-year ended September 30, the company reports a pretax loss of GBP39,602, narrowing from GBP82,631 12 months earlier. Loss is solely down to administrative expenses, which fall 57% from GBP91,327.

----------

By Eric Cunha, Alliance News news editor

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
23 Apr 2021 12:17

Sareum shares rise after improved interim results, research progress

Sareum shares rise after improved interim results, research progress

Read more
16 Feb 2021 13:56

IN BRIEF: Sareum Notes Launch Of UK Government's Agile Platform

IN BRIEF: Sareum Notes Launch Of UK Government's Agile Platform

Read more
7 Jan 2021 12:52

Sareum gets approval for US patent application

(Sharecast News) - Specialist drug development company Sareum announced on Thursday that the United States Patent and Trademark Office has now formally approved its patent application, number 16/351,620.

Read more
7 Jan 2021 10:51

UK WINNERS & LOSERS SUMMARY: Mitchells & Butlers Down Amid Raise Plan

UK WINNERS & LOSERS SUMMARY: Mitchells & Butlers Down Amid Raise Plan

Read more
7 Jan 2021 09:53

Sareum Shares Rise On Granting Of Patent For SDC-1802 Inhibitor

Sareum Shares Rise On Granting Of Patent For SDC-1802 Inhibitor

Read more
16 Dec 2020 22:00

IN BRIEF: Sareum Makes Progress On Potential Covid Treatment Candidate

IN BRIEF: Sareum Makes Progress On Potential Covid Treatment Candidate

Read more
14 Dec 2020 12:27

Sareum Shares Surge 30% After Study Results Support Covid-19 Programme

Sareum Shares Surge 30% After Study Results Support Covid-19 Programme

Read more
8 Dec 2020 15:51

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

Read more
3 Dec 2020 15:45

IN BRIEF: Sareum Gets GBP174,000 To Research Potential Virus Treatment

IN BRIEF: Sareum Gets GBP174,000 To Research Potential Virus Treatment

Read more
3 Dec 2020 12:19

Sareum Holdings secures grant for Covid-19 treatment project

(Sharecast News) - Specialist drug development company Sareum Holdings announced on Thursday that the grant offer letter from UK Research and Innovation (UKRI) had now been received and approved.

Read more
12 Nov 2020 19:17

UK TRADING UPDATE SUMMARY: Clipper Expects 20% Interim Revenue Climb

UK TRADING UPDATE SUMMARY: Clipper Expects 20% Interim Revenue Climb

Read more
27 Oct 2020 15:16

IN BRIEF: Sareum Nets Covid-19 Therapy UK Research Grant

IN BRIEF: Sareum Nets Covid-19 Therapy UK Research Grant

Read more
13 Oct 2020 13:54

IN BRIEF: Sareum Loss Narrows On Reduced Administration Expenses

IN BRIEF: Sareum Loss Narrows On Reduced Administration Expenses

Read more
8 Oct 2020 19:54

UK TRADING UPDATE SUMMARY: Motorpoint Predicts Local Lockdowns Bite

UK TRADING UPDATE SUMMARY: Motorpoint Predicts Local Lockdowns Bite

Read more
8 Oct 2020 15:50

Sareum to get US patent on SDC-1802 programme

(Sharecast News) - Specialist drug development company Sareum announced on Thursday that the United States Patent and Trademark Office (USPTO) has issued a notice of allowance for a patent on an invention associated with its proprietary 'SDC-1802 TYK2/JAK1 Kinase Inhibitor Programme'.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.